Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia. 1998

T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
Laboratoire d'Etude du Metabolisme Azote, Institut National de la Recherche Agronomique, Theix 63122 Ceyrat; Clintec Technologies, 78148 Velizy Cedex, France.

Skeletal muscle catabolism is a characteristic metabolic response to sepsis. We investigated the ability of physiological insulin (2 nM) or insulin-like growth factor I (IGF-I, 10 nM) concentrations to modify protein metabolism during incubation of epitrochlearis 2, 6, or 15 days after injection of live Escherichia coli. On days 2 and 6 postinfection, skeletal muscle exhibited an exacerbated negative protein balance resulting from both an inhibition in protein synthesis (25%) and an enhanced proteolysis (90%) compared with controls. By day 15 postinfection, protein balance in infected rats was significantly improved compared with either day 2 or 6. At this time, protein synthesis was augmented and protein degradation was decreased in infected rats relative to day 6. Insulin or IGF-I stimulated protein synthesis in muscles from septic and control rats in vitro to the same extent at each time point examined. The ability of insulin or IGF-I to limit protein degradation was severely blunted 48 h after infection. On day 6 postinfection, the effect of insulin or IGF-I to inhibit proteolysis was more pronounced than on day 2. Incubation with IGF-I limited proteolysis to a greater extent than insulin on both days in infected but not control rats. By day 15, insulin diminished proteolysis to the same extent as in controls. The results suggest that injection of bacteria causes fundamental derangements in protein metabolism that persist for days after infection.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias

Related Publications

T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
January 2013, Molecular and cellular biochemistry,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
September 1999, Endocrinology,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
April 1974, Federation proceedings,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
October 2003, American journal of physiology. Cell physiology,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
March 1998, Current opinion in clinical nutrition and metabolic care,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
January 1991, The Biochemical journal,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
November 1986, The Biochemical journal,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
March 1992, Growth regulation,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
April 2009, The Journal of trauma,
T C Vary, and D Dardevet, and J Grizard, and L Voisin, and C Buffiere, and P Denis, and D Breuille, and C Obled
December 2006, Gene therapy,
Copied contents to your clipboard!